Congratulations to Flagship Pioneering on raising $3.6 billion to advance critical innovations that propel human health. The industry is at a transformative juncture in our approach to creating new medicines, with incredible scientific breakthroughs and more to come in growing fields such as cell therapy and artificial intelligence. As a company co-founded by Flagship, we appreciate their bold vision for the future of innovative medicines.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO Noubar Afeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: https://bit.ly/4eQfx05